Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
about
Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen speciesCyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidizationIdentification of a three-gene expression signature of poor-prognosis breast carcinomaTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsThe potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingTumor suppressors and cell-cycle proteins in lung cancerTowards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation.Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.Cyclin Cln3p links G1 progression to hyphal and pseudohyphal development in Candida albicans.Multiple regulatory mechanisms to inhibit untimely initiation of DNA replication are important for stable genome maintenance.Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemiaDistinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival.Robustness and backbone motif of a cancer network regulated by miR-17-92 cluster during the G1/S transition.G1/S transcription factor orthologues Swi4p and Swi6p are important but not essential for cell proliferation and influence hyphal development in the fungal pathogen Candida albicans.RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s)Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.Involvement of the INK4a/Arf gene locus in senescence.Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathwaysDepletion of Amyloid Precursor Protein (APP) causes G0 arrest in non-small cell lung cancer (NSCLC) cells.A systems biology dynamical model of mammalian G1 cell cycle progression.CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.Cell cycle regulation during development and dormancy in embryos of the annual killifish Austrofundulus limnaeus.FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior.(-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization.Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.Mip/LIN-9 can inhibit cell proliferation independent of the pocket proteins.A Myc-microRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes.CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activityOncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomasWnt-signaling and senescence: A tug of war in early neoplasia?Inhibition of CDK4/6 protects against radiation-induced intestinal injury in mice.Small molecule regulators of Rb-E2F pathway as modulators of transcription.Fulfilling the metabolic requirements for cell proliferation.Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation.Murine melanoma cells incomplete reprogramming using non-viral vector.An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
P2860
Q24548975-5AA8B870-625C-496A-B0CC-6C785415F021Q24674862-0E493405-0EF6-4462-903A-A30623878851Q24802692-65D0E3BB-00C1-46FB-871F-31D09BD2BB06Q26827580-9FDAF8F1-FF96-45AF-8D23-EB38B01D2AC5Q28087571-188C4099-7BA4-43D7-BC98-2F92BF8ECD5EQ28392478-43210481-ED83-4F3A-8313-EE33EA83307EQ33510472-BD77FC2F-35DA-4B75-A536-D8C256D22014Q33645120-B60B3984-0521-4CF4-A4E2-FCE2CFA86F29Q33719138-765039A8-6606-48A5-90AC-F584A4886442Q33940725-B56F908B-A0A4-4730-AB98-52B2E1390314Q34349298-7FA1B7CB-6C98-49F2-ADBA-A3D63D457C1AQ34387394-C1669E88-E733-42C3-95C6-FED1F48776A6Q34612994-974245AE-6225-41C3-ABEB-A4AA04E7A165Q34739495-82E4EE6C-2DCD-433E-9A98-7FF983F1C91AQ34935948-6222C98D-6743-4E6B-AE32-97B87F20DB8CQ34972742-85ACBDC5-308F-4D69-8338-28073D0C9249Q35010501-4E8993C8-34C1-40E9-96EA-085423920CA5Q35185629-9CE181AD-29E9-4A91-82B1-9F6A4626CC67Q35555383-ED1272E4-9D6F-4885-A446-7E379DB8621FQ35651375-E69685A8-715A-4D60-B016-55BB0E9A05FFQ35689859-3A607781-3319-4E91-9F51-E4215BECD278Q35691269-8A2752A8-992C-40C8-A18A-F16023A1A1ABQ35993101-7BD81E37-9947-489E-B2C0-53B9EC17B60CQ36023723-D2F5AF61-F942-43B7-8C3D-2D2A5C323927Q36027395-9F955DEE-84F2-4A4D-B8DD-CC7CADE9731AQ36057085-69F1C6EE-AF97-4CA1-AC89-1C054947597BQ36170317-29F911A5-9D4E-4C86-A4C8-9FA259CBBFFCQ36308092-B6336188-6121-4C11-B291-FB540FCF114EQ36340840-EFACDF58-403C-4DD6-968B-6299335EFD6BQ36619943-714AD23E-E416-4F20-B332-9D8CF452D845Q37126173-85038FEB-39FC-42E0-9D40-4D37E3AC379AQ37225394-4937A3F5-179C-468F-86B7-2EB0D012B3C9Q37287025-4186F9F8-0519-4C16-87A7-A659387A9E8BQ37395807-619609F1-6166-4E4D-9B0D-EB09AA9658F2Q37773559-5FC5C7DD-05C4-492A-B067-FA028641CFA6Q38029807-54CA6996-F85F-4144-BF17-107D8C6783EFQ38103250-791070E9-D5B5-4AF3-A52A-1D1F63E1DFF8Q38614956-BA1D54CF-A9B2-4D8F-BE6F-34409A8B9B5FQ38700249-F1FB363F-272E-4CB8-8EC4-80369E4A7E43Q38718996-D9885B87-0D6E-473B-8F71-773A74894F4C
P2860
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
@ast
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
@en
type
label
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
@ast
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
@en
prefLabel
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
@ast
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
@en
P1476
Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.
@en
P2093
Steven F Dowdy
P356
10.1016/S0959-437X(01)00263-5
P577
2002-02-01T00:00:00Z